2019 Q3 Form 10-Q Financial Statement
#000156459019043470 Filed on November 14, 2019
Income Statement
| Concept | 2019 Q3 | 2018 Q3 |
|---|---|---|
| Revenue | $11.65M | $10.21M |
| YoY Change | 14.16% | -23.62% |
| Cost Of Revenue | $4.344M | $3.917M |
| YoY Change | 10.9% | 470.16% |
| Gross Profit | $7.308M | $8.135M |
| YoY Change | -10.17% | -35.82% |
| Gross Profit Margin | 62.72% | 79.7% |
| Selling, General & Admin | $6.090M | $7.201M |
| YoY Change | -15.43% | 2.43% |
| % of Gross Profit | 83.33% | 88.52% |
| Research & Development | ||
| YoY Change | ||
| % of Gross Profit | ||
| Depreciation & Amortization | $335.0K | $418.0K |
| YoY Change | -19.86% | -2.79% |
| % of Gross Profit | 4.58% | 5.14% |
| Operating Expenses | $7.528M | $8.893M |
| YoY Change | -15.35% | -33.35% |
| Operating Profit | -$220.0K | -$758.0K |
| YoY Change | -70.98% | 665.66% |
| Interest Expense | $30.00K | $61.00K |
| YoY Change | -50.82% | -51.97% |
| % of Operating Profit | ||
| Other Income/Expense, Net | ||
| YoY Change | ||
| Pretax Income | -$143.0K | -$786.0K |
| YoY Change | -81.81% | 250.89% |
| Income Tax | $0.00 | $0.00 |
| % Of Pretax Income | ||
| Net Earnings | -$261.0K | -$880.0K |
| YoY Change | -70.34% | 217.69% |
| Net Earnings / Revenue | -2.24% | -8.62% |
| Basic Earnings Per Share | -$0.04 | -$0.12 |
| Diluted Earnings Per Share | -$0.04 | -$0.12 |
| COMMON SHARES | ||
| Basic Shares Outstanding | 6.987M | 7.347M |
| Diluted Shares Outstanding | 6.987M | 7.347M |
Balance Sheet
| Concept | 2019 Q3 | 2018 Q3 |
|---|---|---|
| SHORT-TERM ASSETS | ||
| Cash & Short-Term Investments | $7.670M | $3.393M |
| YoY Change | 126.05% | -65.73% |
| Cash & Equivalents | $7.670M | $3.393M |
| Short-Term Investments | ||
| Other Short-Term Assets | $2.271M | $2.687M |
| YoY Change | -15.48% | -38.93% |
| Inventory | $1.989M | $1.905M |
| Prepaid Expenses | ||
| Receivables | $5.136M | $4.606M |
| Other Receivables | $0.00 | $0.00 |
| Total Short-Term Assets | $17.07M | $12.59M |
| YoY Change | 35.54% | -44.08% |
| LONG-TERM ASSETS | ||
| Property, Plant & Equipment | $5.189M | $10.47M |
| YoY Change | -50.46% | -0.92% |
| Goodwill | ||
| YoY Change | ||
| Intangibles | $1.324M | $1.441M |
| YoY Change | -8.12% | -7.51% |
| Long-Term Investments | ||
| YoY Change | ||
| Other Assets | $762.0K | $902.0K |
| YoY Change | -15.52% | 19.15% |
| Total Long-Term Assets | $5.757M | $13.12M |
| YoY Change | -56.13% | 1.83% |
| TOTAL ASSETS | ||
| Total Short-Term Assets | $17.07M | $12.59M |
| Total Long-Term Assets | $5.757M | $13.12M |
| Total Assets | $22.82M | $25.71M |
| YoY Change | -11.24% | -27.37% |
| SHORT-TERM LIABILITIES | ||
| YoY Change | ||
| Accounts Payable | $1.555M | $1.432M |
| YoY Change | 8.59% | -24.51% |
| Accrued Expenses | $4.918M | $542.0K |
| YoY Change | 807.38% | -15.97% |
| Deferred Revenue | ||
| YoY Change | ||
| Short-Term Debt | $0.00 | $0.00 |
| YoY Change | ||
| Long-Term Debt Due | $2.772M | $260.0K |
| YoY Change | 966.15% | -96.05% |
| Total Short-Term Liabilities | $9.245M | $5.398M |
| YoY Change | 71.27% | -57.36% |
| LONG-TERM LIABILITIES | ||
| Long-Term Debt | $115.0K | $2.737M |
| YoY Change | -95.8% | |
| Other Long-Term Liabilities | $157.0K | $330.0K |
| YoY Change | -52.42% | 2.8% |
| Total Long-Term Liabilities | $1.756M | $4.008M |
| YoY Change | -56.19% | 203.18% |
| TOTAL LIABILITIES | ||
| Total Short-Term Liabilities | $9.245M | $5.398M |
| Total Long-Term Liabilities | $1.756M | $4.008M |
| Total Liabilities | $11.00M | $9.406M |
| YoY Change | 16.96% | -32.72% |
| SHAREHOLDERS EQUITY | ||
| Retained Earnings | $797.0K | $1.863M |
| YoY Change | -57.22% | -54.1% |
| Common Stock | $14.27M | $14.62M |
| YoY Change | -2.43% | -17.35% |
| Preferred Stock | ||
| YoY Change | ||
| Treasury Stock (at cost) | ||
| YoY Change | ||
| Treasury Stock Shares | ||
| Shareholders Equity | $14.81M | $16.31M |
| YoY Change | ||
| Total Liabilities & Shareholders Equity | $25.81M | $25.71M |
| YoY Change | 0.38% | -27.37% |
Cashflow Statement
| Concept | 2019 Q3 | 2018 Q3 |
|---|---|---|
| OPERATING ACTIVITIES | ||
| Net Income | -$261.0K | -$880.0K |
| YoY Change | -70.34% | 217.69% |
| Depreciation, Depletion And Amortization | $335.0K | $418.0K |
| YoY Change | -19.86% | -2.79% |
| Cash From Operating Activities | -$95.00K | $458.0K |
| YoY Change | -120.74% | 96.57% |
| INVESTING ACTIVITIES | ||
| Capital Expenditures | $251.0K | $412.0K |
| YoY Change | -39.08% | -39.77% |
| Acquisitions | ||
| YoY Change | ||
| Other Investing Activities | $355.0K | $2.000K |
| YoY Change | 17650.0% | |
| Cash From Investing Activities | $104.0K | -$454.0K |
| YoY Change | -122.91% | -33.43% |
| FINANCING ACTIVITIES | ||
| Cash Dividend Paid | ||
| YoY Change | ||
| Common Stock Issuance & Retirement, Net | ||
| YoY Change | ||
| Debt Paid & Issued, Net | $81.00K | $67.00K |
| YoY Change | 20.9% | -50.74% |
| Cash From Financing Activities | -81.00K | -67.00K |
| YoY Change | 20.9% | -50.74% |
| NET CHANGE | ||
| Cash From Operating Activities | -95.00K | 458.0K |
| Cash From Investing Activities | 104.0K | -454.0K |
| Cash From Financing Activities | -81.00K | -67.00K |
| Net Change In Cash | -72.00K | -63.00K |
| YoY Change | 14.29% | -89.23% |
| FREE CASH FLOW | ||
| Cash From Operating Activities | -$95.00K | $458.0K |
| Capital Expenditures | $251.0K | $412.0K |
| Free Cash Flow | -$346.0K | $46.00K |
| YoY Change | -852.17% | -110.2% |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| CY2019Q2 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
2000000 | |
| CY2019Q2 | us-gaap |
Preferred Stock Share Subscriptions
PreferredStockShareSubscriptions
|
2000000 | |
| CY2019Q3 | us-gaap |
Common Stock No Par Value
CommonStockNoParValue
|
||
| CY2019Q3 | dei |
Entity Address Postal Zip Code
EntityAddressPostalZipCode
|
30339 | |
| CY2019Q2 | us-gaap |
Long Term Debt Current
LongTermDebtCurrent
|
2836000 | |
| CY2019Q2 | us-gaap |
Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
|
843000 | |
| CY2019Q3 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
498000 | |
| CY2019Q3 | us-gaap |
Labor And Related Expense
LaborAndRelatedExpense
|
4909000 | |
| CY2019Q3 | us-gaap |
Supplies Expense
SuppliesExpense
|
319000 | |
| CY2019Q3 | us-gaap |
Other Cost And Expense Operating
OtherCostAndExpenseOperating
|
1103000 | |
| CY2019Q3 | us-gaap |
Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
|
159000 | |
| CY2019Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-220000 | |
| CY2018Q3 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
338000 | |
| CY2018Q3 | us-gaap |
Labor And Related Expense
LaborAndRelatedExpense
|
4674000 | |
| CY2018Q3 | us-gaap |
Supplies Expense
SuppliesExpense
|
288000 | |
| CY2018Q3 | us-gaap |
Other Cost And Expense Operating
OtherCostAndExpenseOperating
|
1013000 | |
| CY2018Q3 | us-gaap |
Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
|
135000 | |
| CY2018Q3 | us-gaap |
Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
|
2000 | |
| CY2019Q2 | us-gaap |
Common Stock Value
CommonStockValue
|
3493000 | |
| CY2019Q2 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
6987000 | |
| CY2019Q2 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
||
| CY2019Q2 | us-gaap |
Common Stock No Par Value
CommonStockNoParValue
|
||
| CY2019Q3 | dei |
Entity Address Address Line1
EntityAddressAddressLine1
|
900 Circle 75 Parkway | |
| CY2019Q3 | dei |
Entity Address Address Line2
EntityAddressAddressLine2
|
Suite 1120 | |
| CY2019Q3 | dei |
Entity Address City Or Town
EntityAddressCityOrTown
|
Atlanta | |
| CY2019Q3 | dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
false | |
| CY2019Q3 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-143000 | |
| CY2018Q3 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-786000 | |
| CY2019Q3 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | |
| CY2018Q3 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | |
| CY2019Q2 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
6987000 | |
| CY2019Q2 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
134000 | |
| CY2019Q2 | us-gaap |
Liabilities Noncurrent
LiabilitiesNoncurrent
|
966000 | |
| CY2019Q2 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
0 | |
| CY2019Q2 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
24419000 | |
| CY2018Q3 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
10207000 | |
| CY2019Q2 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
10745000 | |
| CY2019Q2 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
-253000 | |
| CY2019Q2 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
1058000 | |
| CY2019Q3 | dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | |
| CY2019Q3 | dei |
Entity Shell Company
EntityShellCompany
|
false | |
| CY2019Q3 | us-gaap |
Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
|
1324000 | |
| CY2019Q4 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
6986855 | |
| CY2019Q3 | dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
OH | |
| CY2019Q3 | dei |
Entity Tax Identification Number
EntityTaxIdentificationNumber
|
31-0621189 | |
| CY2019Q3 | dei |
Entity Address State Or Province
EntityAddressStateOrProvince
|
GA | |
| CY2019Q3 | dei |
City Area Code
CityAreaCode
|
770 | |
| CY2019Q3 | dei |
Local Phone Number
LocalPhoneNumber
|
933-7000 | |
| CY2019Q3 | dei |
Document Quarterly Report
DocumentQuarterlyReport
|
true | |
| CY2019Q3 | dei |
Document Transition Report
DocumentTransitionReport
|
false | |
| CY2019Q3 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
7670000 | |
| CY2019Q3 | us-gaap |
Receivables Net Current
ReceivablesNetCurrent
|
5136000 | |
| CY2019Q2 | us-gaap |
Assets Current
AssetsCurrent
|
16658000 | |
| CY2019Q3 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
19742000 | |
| CY2019Q3 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
5189000 | |
| CY2019Q3 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
14553000 | |
| CY2019Q3 | dei |
Entity Small Business
EntitySmallBusiness
|
true | |
| CY2019Q3 | dei |
Entity File Number
EntityFileNumber
|
1-12607 | |
| CY2019Q3 | us-gaap |
Inventory Net
InventoryNet
|
1989000 | |
| CY2019Q2 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
2185000 | |
| CY2019Q3 | us-gaap |
Assets Current
AssetsCurrent
|
17066000 | |
| CY2019Q3 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
11652000 | |
| CY2019Q2 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
15043000 | |
| CY2019Q3 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
0 | |
| CY2019Q3 | us-gaap |
Common Stock Value
CommonStockValue
|
3493000 | |
| CY2019Q3 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
797000 | |
| CY2019Q3 | us-gaap |
Income Taxes Receivable Noncurrent
IncomeTaxesReceivableNoncurrent
|
153000 | |
| CY2019Q3 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
-253000 | |
| CY2019Q3 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
14810000 | |
| CY2019Q3 | ssy |
Assets Held For Sale Not Part Of Disposal Group Noncurrent
AssetsHeldForSaleNotPartOfDisposalGroupNoncurrent
|
0 | |
| CY2019Q3 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
25811000 | |
| CY2019Q3 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
6987000 | |
| CY2019Q2 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
1960000 | |
| CY2019Q3 | us-gaap |
Other Liabilities Current
OtherLiabilitiesCurrent
|
1164000 | |
| CY2019Q3 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
6987000 | |
| CY2019Q3 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
9245000 | |
| CY2019Q2 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
763000 | |
| CY2019Q2 | us-gaap |
Assets Noncurrent Other Than Noncurrent Investments And Property Plant And Equipment
AssetsNoncurrentOtherThanNoncurrentInvestmentsAndPropertyPlantAndEquipment
|
2518000 | |
| CY2019Q3 | us-gaap |
Long Term Debt Noncurrent
LongTermDebtNoncurrent
|
115000 | |
| CY2019Q3 | ssy |
Professional Liability Risks Non Current
ProfessionalLiabilityRisksNonCurrent
|
662000 | |
| CY2019Q3 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
822000 | |
| CY2019Q3 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
157000 | |
| CY2019Q3 | us-gaap |
Liabilities Noncurrent
LiabilitiesNoncurrent
|
1756000 | |
| CY2019Q3 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
||
| CY2019Q3 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
10773000 | |
| CY2019Q3 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
2271000 | |
| CY2019Q3 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
2000000 | |
| CY2019Q3 | us-gaap |
Preferred Stock Share Subscriptions
PreferredStockShareSubscriptions
|
2000000 | |
| CY2019Q2 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
0 | |
| CY2019Q2 | us-gaap |
Assets
Assets
|
24419000 | |
| CY2019Q2 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
1564000 | |
| CY2019Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-261000 | |
| CY2019Q3 | us-gaap |
Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
0 | |
| CY2018Q3 | us-gaap |
Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
0 | |
| CY2019Q3 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-261000 | |
| CY2018Q3 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-880000 | |
| CY2019Q3 | us-gaap |
Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
|
-0.02 | |
| CY2018Q3 | us-gaap |
Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
|
-0.11 | |
| CY2019Q3 | us-gaap |
Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
|
-0.02 | |
| CY2018Q3 | us-gaap |
Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
|
-0.11 | |
| CY2019Q3 | us-gaap |
Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
|
-0.02 | |
| CY2018Q3 | us-gaap |
Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
|
-0.01 | |
| CY2019Q3 | us-gaap |
Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
|
-0.02 | |
| CY2018Q3 | us-gaap |
Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
|
-0.01 | |
| CY2019Q3 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.04 | |
| CY2018Q3 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.12 | |
| CY2019Q3 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.04 | |
| CY2018Q3 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.12 | |
| CY2019Q3 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
6987000 | |
| CY2018Q3 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
7347000 | |
| CY2019Q3 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
6987000 | |
| CY2018Q3 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
7347000 | |
| CY2019Q3 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
|
261000 | |
| CY2019Q3 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
|
104000 | |
| CY2019Q3 | us-gaap |
Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
|
1607000 | |
| CY2019Q3 | us-gaap |
Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
|
287000 | |
| CY2019Q3 | us-gaap |
Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
|
107000 | |
| CY2019Q3 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
1320000 | |
| CY2019Q3 | us-gaap |
Finance Lease Liability Payments Remainder Of Fiscal Year
FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
|
31000 | |
| CY2018Q3 | ssy |
Payments To Acquire Property Plant And Equipment Continuing Operations
PaymentsToAcquirePropertyPlantAndEquipmentContinuingOperations
|
412000 | |
| CY2018Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
3393000 | |
| CY2019Q3 | us-gaap |
Interest Paid Net
InterestPaidNet
|
52000 | |
| CY2018Q3 | us-gaap |
Interest Paid Net
InterestPaidNet
|
55000 | |
| CY2019Q3 | us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
-11000 | |
| CY2018Q3 | us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
0 | |
| CY2019Q3 | us-gaap |
Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
|
0 | |
| CY2019Q3 | us-gaap |
Interest Expense
InterestExpense
|
30000 | |
| CY2019Q3 | us-gaap |
Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
|
-143000 | |
| CY2018Q3 | us-gaap |
Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
|
-786000 | |
| CY2019Q3 | us-gaap |
Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
|
-118000 | |
| CY2018Q3 | us-gaap |
Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
|
-94000 | |
| CY2018Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-880000 | |
| CY2019Q3 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-95000 | |
| CY2018Q3 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
458000 | |
| CY2019Q3 | ssy |
Payments To Acquire Property Plant And Equipment Continuing Operations
PaymentsToAcquirePropertyPlantAndEquipmentContinuingOperations
|
251000 | |
| CY2019Q3 | ssy |
Payments To Acquire Property Plant And Equipment Discontinuing Operations
PaymentsToAcquirePropertyPlantAndEquipmentDiscontinuingOperations
|
0 | |
| CY2018Q3 | ssy |
Payments To Acquire Property Plant And Equipment Discontinuing Operations
PaymentsToAcquirePropertyPlantAndEquipmentDiscontinuingOperations
|
44000 | |
| CY2019Q3 | us-gaap |
Proceeds From Sale Of Other Assets Investing Activities
ProceedsFromSaleOfOtherAssetsInvestingActivities
|
355000 | |
| CY2018Q3 | us-gaap |
Proceeds From Sale Of Other Assets Investing Activities
ProceedsFromSaleOfOtherAssetsInvestingActivities
|
2000 | |
| CY2019Q3 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
104000 | |
| CY2018Q3 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-454000 | |
| CY2019Q3 | us-gaap |
Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
|
81000 | |
| CY2018Q3 | us-gaap |
Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
|
67000 | |
| CY2019Q3 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-81000 | |
| CY2018Q3 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-67000 | |
| CY2019Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
-72000 | |
| CY2018Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
-63000 | |
| CY2019Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
7742000 | |
| CY2018Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
3456000 | |
| CY2019Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
7670000 | |
| CY2018Q3 | us-gaap |
Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
|
0 | |
| CY2019Q3 | us-gaap |
Nature Of Operations
NatureOfOperations
|
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Note 2. – Business Operations</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Business Operations</font></p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">SunLink Health Systems, Inc., through subsidiaries owns businesses which are providers of healthcare services in certain markets in the United States. SunLink’s business is composed of the ownership of two business segments:</p> <p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Healthcare Services</p> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:4.25%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"> </p></td> <td valign="top" style="width:4.25%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:'Times New Roman'">•</font></p></td> <td valign="top"> <p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"><font style="font-family:Times New Roman;">A subsidiary which owns and operates Trace Regional Hospital and Floy Dyer Nursing Home (“Trace”), an 84 licensed-bed acute care hospital, located in Houston, Mississippi, which includes an 18-bed geriatric psychology unit (“GPU”), and a 66-bed nursing home. This facility focuses primarily on senior healthcare services.</font></p></td></tr></table></div> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:4.25%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"> </p></td> <td valign="top" style="width:4.25%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:'Times New Roman'">•</font></p></td> <td valign="top"> <p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"><font style="font-family:Symbol;"><font style="font-size:10pt;font-family:'Times New Roman'">A</font></font><font style="font-family:Times New Roman;"> subsidiary which owns a medical building and approximately four (4) acres of land in Clanton, Alabama. A portion of the medical office building is currently partially rented to two tenants.</font> </p></td></tr></table></div> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:4.25%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"> </p></td> <td valign="top" style="width:4.25%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:'Times New Roman'">•</font></p></td> <td valign="top"> <p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"><font style="font-family:Symbol;"><font style="font-size:10pt;font-family:'Times New Roman'">A</font><font style="font-size:10pt;font-family:'Times New Roman'"> </font></font><font style="font-family:Times New Roman;">subsidiary which owns approximately five (5) acres of unimproved land in Houston, Mississippi</font>. </p></td></tr></table></div> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:4.25%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"> </p></td> <td valign="top" style="width:4.25%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:'Times New Roman'">•</font></p></td> <td valign="top"> <p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"><font style="font-family:Times New Roman;">A subsidiary, SunLink Health Systems Technology (SHS Technology), which provides information technology (IT) to outside customers and to SunLink subsidiaries.</font></p></td></tr></table></div> <p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Pharmacy</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Pharmacy segment, which is composed of four operational areas:</p> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:4.25%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"> </p></td> <td valign="top" style="width:4.25%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:'Times New Roman'">•</font></p></td> <td valign="top"> <p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"><font style="font-family:Times New Roman;">Retail pharmacy products and services, consisting of retail pharmacy sales conducted in rural markets at two locations in Louisiana.</font> </p></td></tr></table></div> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:4.25%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"> </p></td> <td valign="top" style="width:4.25%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:'Times New Roman'">•</font></p></td> <td valign="top"> <p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"><font style="font-family:Times New Roman;">Institutional pharmacy services consisting of the provision of specialty and non-specialty pharmaceutical and biological products to institutional clients or to patients in institutional settings, such as nursing homes, assisted living facilities, behavioral and specialty hospitals, hospice, and correctional facilities.</font></p></td></tr></table></div> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:4.25%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"> </p></td> <td valign="top" style="width:4.25%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:'Times New Roman'">•</font><font style="font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </font><font style="font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </font></p></td> <td valign="top"> <p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"><font style="font-family:Times New Roman;">Non-institutional pharmacy services consisting of the provision of specialty and non-specialty pharmaceutical and biological products to clients or patients in non-institutional settings including private residential homes. </font></p></td></tr></table></div> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:4.25%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"> </p></td> <td valign="top" style="width:4.25%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:'Times New Roman'">•</font><font style="font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font></p></td> <td valign="top"> <p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"><font style="font-size:10pt;font-family:'Times New Roman'"> </font><font style="font-family:Times New Roman;">Durable medical equipment products and services (“DME”), consisting primarily of the sale and rental of products for institutional clients or to patients in institutional settings and patient-administered home care.</font></p></td></tr></table></div> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">SunLink subsidiaries have conducted the Healthcare Services business since 2001 and the Pharmacy operations since 2008. Our Pharmacy segment currently is operated through Carmichael’s Cashway Pharmacy, Inc. (“Carmichael”), a subsidiary of our SunLink ScriptsRx, LLC subsidiary. </p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</p> | |
| CY2019Q3 | us-gaap |
Number Of Reportable Segments
NumberOfReportableSegments
|
2 | |
| CY2019Q3 | us-gaap |
Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
|
9000 | |
| CY2019Q3 | ssy |
Disposal Group Including Discontinued Operation Revenue Net Of Expenses
DisposalGroupIncludingDiscontinuedOperationRevenueNetOfExpenses
|
24000 | |
| CY2018Q3 | ssy |
Disposal Group Including Discontinued Operation Revenue Net Of Expenses
DisposalGroupIncludingDiscontinuedOperationRevenueNetOfExpenses
|
1852000 | |
| CY2019Q3 | us-gaap |
Finance Lease Interest Expense
FinanceLeaseInterestExpense
|
3000 | |
| CY2019Q3 | us-gaap |
Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
|
-118000 | |
| CY2018Q3 | us-gaap |
Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
|
-94000 | |
| CY2019Q3 | us-gaap |
Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
|
0 | |
| CY2018Q3 | us-gaap |
Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
|
0 | |
| CY2019Q3 | us-gaap |
Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
|
359959 | |
| CY2019Q3 | ssy |
Share Repurchase Average Price Per Share Paid
ShareRepurchaseAveragePricePerSharePaid
|
1.03 | |
| CY2019Q3 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
28000 | |
| CY2019Q3 | us-gaap |
Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
|
5598000 | |
| CY2019Q2 | us-gaap |
Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
|
5230000 | |
| CY2019Q3 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
462000 | |
| CY2019Q2 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
515000 | |
| CY2019Q3 | us-gaap |
Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
|
145000 | |
| CY2018Q2 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
529000 | |
| CY2018Q3 | us-gaap |
Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
|
209000 | |
| CY2018Q3 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
451000 | |
| CY2019Q3 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
29000 | |
| CY2018Q3 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
29000 | |
| CY2019Q3 | us-gaap |
Capital Lease Obligations
CapitalLeaseObligations
|
148000 | |
| CY2019Q2 | us-gaap |
Capital Lease Obligations
CapitalLeaseObligations
|
159000 | |
| CY2019Q3 | us-gaap |
Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
|
189000 | |
| CY2019Q2 | us-gaap |
Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
|
195000 | |
| CY2019Q3 | us-gaap |
Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
|
0 | |
| CY2018Q3 | us-gaap |
Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
|
0 | |
| CY2019Q3 | us-gaap |
Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
|
0 | |
| CY2018Q3 | us-gaap |
Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
|
0 | |
| CY2019Q3 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
8673000 | |
| CY2019Q3 | us-gaap |
Deferred Tax Assets Liabilities Net Noncurrent
DeferredTaxAssetsLiabilitiesNetNoncurrent
|
0 | |
| CY2019Q3 | us-gaap |
Operating Loss Carryforwards
OperatingLossCarryforwards
|
18200000 | |
| CY2019Q3 | ssy |
Net Operating Loss Carry Forwards Expire Period
NetOperatingLossCarryForwardsExpirePeriod
|
2023 through fiscal 2038 | |
| CY2019Q3 | us-gaap |
Operating Lease Cost
OperatingLeaseCost
|
147000 | |
| CY2019Q3 | us-gaap |
Short Term Lease Cost
ShortTermLeaseCost
|
5000 | |
| CY2019Q3 | ssy |
Operating Variable Lease Cost
OperatingVariableLeaseCost
|
7000 | |
| CY2019Q3 | us-gaap |
Operating Lease Expense
OperatingLeaseExpense
|
159000 | |
| CY2019Q3 | ssy |
Finance Lease Cost
FinanceLeaseCost
|
12000 | |
| CY2019Q3 | us-gaap |
Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
|
203000 | |
| CY2019Q3 | us-gaap |
Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List
FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
|
us-gaap:PropertyPlantAndEquipmentNet | |
| CY2019Q3 | us-gaap |
Property Plant And Equipment Owned Accumulated Depreciation
PropertyPlantAndEquipmentOwnedAccumulatedDepreciation
|
22000 | |
| CY2019Q3 | us-gaap |
Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
|
33000 | |
| CY2019Q3 | us-gaap |
Finance Lease Liability Current Statement Of Financial Position Extensible List
FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
|
us-gaap:LongTermDebtCurrent | |
| CY2019Q3 | us-gaap |
Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
|
115000 | |
| CY2019Q3 | us-gaap |
Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List
FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
|
us-gaap:LongTermDebtNoncurrent | |
| CY2019Q3 | us-gaap |
Operating Lease Payments
OperatingLeasePayments
|
139000 | |
| CY2019Q3 | ssy |
Operating Cash Flows From Finance Lease
OperatingCashFlowsFromFinanceLease
|
3000 | |
| CY2019Q3 | us-gaap |
Finance Lease Principal Payments
FinanceLeasePrincipalPayments
|
8000 | |
| CY2019Q3 | us-gaap |
Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
|
0 | |
| CY2019Q3 | us-gaap |
Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
|
148000 | |
| CY2019Q3 | us-gaap |
Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
|
P4Y1M28D | |
| CY2019Q3 | us-gaap |
Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
|
P3Y10M2D | |
| CY2019Q3 | us-gaap |
Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
|
0.0654 | |
| CY2019Q3 | us-gaap |
Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
|
0.0553 | |
| CY2019Q3 | us-gaap |
Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
|
579000 | |
| CY2019Q3 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
|
392000 | |
| CY2019Q3 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
|
271000 | |
| CY2019Q3 | us-gaap |
Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
|
42000 | |
| CY2019Q3 | us-gaap |
Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
|
42000 | |
| CY2019Q3 | us-gaap |
Finance Lease Liability Payments Due Year Four
FinanceLeaseLiabilityPaymentsDueYearFour
|
41000 | |
| CY2019Q3 | us-gaap |
Finance Lease Liability Payments Due Year Five
FinanceLeaseLiabilityPaymentsDueYearFive
|
17000 | |
| CY2019Q3 | us-gaap |
Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
|
173000 | |
| CY2019Q3 | us-gaap |
Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
|
25000 | |
| CY2019Q3 | us-gaap |
Finance Lease Liability
FinanceLeaseLiability
|
148000 | |
| CY2019Q3 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
251000 | |
| CY2018Q3 | us-gaap |
Assets
Assets
|
25713000 | |
| CY2018Q3 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
412000 |
